Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Guadecitabine sodium by Astex Pharmaceuticals for Chondrosarcoma: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Chondrosarcoma. According to GlobalData, Phase...
Guadecitabine sodium by Astex Pharmaceuticals for Non-Small Cell Lung Cancer: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Non-Small Cell Lung Cancer. According...
Guadecitabine sodium by Astex Pharmaceuticals for Small-Cell Lung Cancer: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Small-Cell Lung Cancer. According to...
Guadecitabine sodium by Astex Pharmaceuticals for Small-Cell Lung Cancer: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Small-Cell Lung Cancer. According to...